Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
PALO ALTO, Calif.--(BUSINESS WIRE)--
Robert Bosch Healthcare Systems, Inc. (Bosch Healthcare) announced today
an agreement with Abbott's diabetes care business for a non-exclusive
license under select Bosch Healthcare patents, for use in the diabetes
field, following the termination of a previously established exclusive
license agreement. As a result of these actions, Bosch Healthcare has
reacquired sublicense rights under more than 150 issued patents and more
than 40 patent applications for use in the diabetes field. These patents
and patent applications are now available for licensing to healthcare
companies focused on developing products and services for the management
and/or monitoring of individuals with chronic medical conditions,
including diabetes. The Bosch Healthcare patents include those which are
directed at the collection of insulin dosage information, blood glucose
readings and other laboratory data associated with diabetes management,
monitoring and treatment.
According to Dr. Jasper zu Putlitz, M.D., president of Bosch Healthcare
Systems, Diabetes impacts millions of Americans, of all ages. The need
to monitor and manage diabetes, and its symptoms continues to grow as
does the need to prevent the complications of diabetes. Bosch Healthcare
seeks to work with those companies that share our concern and are using
innovation to help manage diabetes and other chronic medical conditions.
Companies interested in establishing a licensing agreement under Bosch
Healthcare patents should contact Greg Mathis.
Licensing Contact:Robert Bosch Healthcare Systems, Inc.Greg
Mathis, +1 650-690-9103Greg.Mathis@us.bosch.comorMedia
Contact:Robert Bosch Healthcare Systems, Inc.Bill Broderick,
Source: Robert Bosch Healthcare Systems, Inc.